ایران دارو
دیران | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 22,480 2.98
Close Price: 22,480
Financial Ratios
AGM
Interim
2026/05/20 Fiscal Year 2025/12/2112 Month | 2025/04/20 Fiscal Year 2024/12/2012 Month | 2024/04/17 Fiscal Year 2023/12/2112 Month | ||
|---|---|---|---|---|
Net Profit to Sales | 4.21 | 0.3 | 17.62 | |
Gross Profit to Sales | 8.77 | 2.03 | 21.34 | |
Operating Margin | 31.63 | 21.46 | 32.61 | |
Gross Profit to Sales | 39.48 | 28.22 | 36.76 | |
Net Profit to Gross Profit | 10.66 | 1.07 | 47.92 | |
Return on Assets (ROA) | 3.37 | 0.19 | 13.46 | |
Return on Capital (%) | 20.42 | 0.98 | 105.34 | |
Return on Equity (ROE) | 14.39 | 0.83 | 41.08 | |
Working Capital Return | 9.16 | 0.49 | 41.03 | |
Fixed Asset Return | 102.31 | 7.1 | 570.34 | |
Loan Benefit Assessment | 4.27 | 4.31 | 3.05 | |
Current Ratio | 1.62 | 1.7 | 1.51 | |
Quick Ratio | 1.29 | 1.43 | 1.18 | |
Liquidity Ratio | 0.01 | 0.02 | 0.06 | |
Net Working Capital | 3,968,545 | 3,605,148 | 2,259,564 | |
Current Assets Ratio | 0.96 | 0.97 | 0.97 | |
Inventory Turnover | 122.96 | 123.67 | 148.09 | |
Receivables Collection Period | 301.41 | 430.78 | 332.77 | |
Inventory to Working Capital | 0.54 | 0.38 | 0.64 | |
Working Capital Turnover | 2.18 | 1.61 | 2.33 | |
Fixed Asset Turnover | 24.31 | 23.55 | 32.37 | |
Total Asset Turnover | 0.8 | 0.64 | 0.76 | |
Debt Ratio | 0.77 | 0.77 | 0.67 | |
Debt to Equity | 3.27 | 3.31 | 2.05 | |
Long-Term Debt to Equity | 0.75 | 0.85 | 0.08 | |
Current Debt to Equity | 2.52 | 2.46 | 1.97 | |
Equity Ratio | 23.45 | 23.21 | 32.77 | |
Debt Coverage Ratio | 0.19 | 0.14 | 0.87 |
